Scherm­afbeelding 2025 01 21 om 11.12.24

Beckman Coulter modernises South West London Pathology diagnostic capabilities with advanced laboratory installation

South West London Pathology (SWLP) has initiated a comprehensive modernisation of its clinical blood science services, beginning with the installation of state-of-the-art analysers at Croydon Hospital. This development marks the first phase of a broader implementation strategy across the SWLP network, encompassing clinical chemistry, haematology, coagulation, serology, and pre-analytical automation systems.

paul geeleher

Scientists develop GPU-powered AI tool to analyse single-cell gene data

A new machine learning algorithm developed by St. Jude Children’s Research Hospital researchers enables faster and more accurate analysis of large-scale single-cell gene expression datasets, potentially accelerating discoveries in cancer and other diseases.

extracellular vesicles

BKCa channels identified as essential regulators of extracellular vesicle integrity

Scientists have discovered how extracellular vesicles maintain their structural integrity during cellular transport through blood vessels and bodily fluids, revealing a critical role for specialised ion channels that regulate internal conditions.

chlorine

Novel photocatalytic process enables precise chlorination for drug development

A breakthrough in chemical synthesis methodology offers pharmaceutical manufacturers a more environmentally sustainable approach to incorporating chlorine into drug compounds, with implications for both process efficiency and molecular modification.

Kai Tan

CelloType: Novel AI model promises better cell analysis in tissue samples

Children’s Hospital of Philadelphia researchers have developed an advanced artificial intelligence model that can simultaneously identify and classify cells in complex tissue samples, potentially transforming how diseases are studied and diagnosed at the cellular level.

GSK logo

GSK acquires IDRx in $1.15bn GIST therapy deal

GlaxoSmithKline (GSK) has entered into an agreement to acquire Boston-based IDRx for up to $1.15 billion, securing rights to IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST). The deal comprises an upfront payment of $1 billion and a potential $150 million regulatory milestone payment.

biorad columns

Bio-Rad expands process-scale chromatography range with 45 cm ID prepacked column

Bio-Rad Laboratories has enhanced its downstream bioprocessing capabilities with larger-diameter prepacked chromatography columns. The expansion builds upon their existing Foresight Pro range, offering increased scalability options for the purification of biotherapeutics including monoclonal antibodies, recombinant proteins, and vaccines.

mindray PLT

Mindray launches novel platelet counting technology for clinical laboratories

International medical technology company Mindray has introduced new platelet counting technology to European markets, incorporating artificial intelligence and multiple detection methods to enhance accuracy in clinical haematology laboratories. The CAL 8000 Cellular Analysis Line aims to reduce pseudothrombocytopenia and pseudothrombocytosis errors in diagnostic testing.

torrey pines Jan 2025

Torrey Pines Scientific introduces programmable multi-position stirring hot plate

A programmable five-position stirring hot plate offering precise temperature control and multiple stirring positions has been launched by Torrey Pines Scientific. The EchoTherm Model HS65 aims to enhance laboratory workflow efficiency in chemical, pharmaceutical, environmental and biochemical applications where reproducible sample preparation is essential.

panakeia logo

Panakeia introduces AI software for rapid MSI/dMMR detection in colorectal cancer

Cambridge-based Panakeia has announced PANProfiler Colon, an artificial intelligence-driven software tool that determines micro-satellite instability (MSI) and mismatch repair deficiency (dMMR) status from H&E-stained tissue samples within minutes. The technology aims to accelerate molecular profiling for precision medicine in colorectal cancer treatment.